169 related articles for article (PubMed ID: 32203929)
21. Effect of BCG Vaccination against SARS-CoV-2 Infection.
Li YP; Cai JW; Liao LJ; Ding H; Cao XJ; Zhu GD; Guo XG
Jpn J Infect Dis; 2022 May; 75(3):302-308. PubMed ID: 34853192
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India.
Zodpey SP; Ambadekar NN; Thakur A
Public Health; 2005 Mar; 119(3):209-16. PubMed ID: 15661132
[TBL] [Abstract][Full Text] [Related]
23. The association between Bacillus Calmette-Guérin vaccination (1331 SSI) skin reaction and subsequent scar development in infants.
Birk NM; Nissen TN; Ladekarl M; Zingmark V; Kjærgaard J; Jensen TM; Jensen SK; Thøstesen LM; Kofoed PE; Stensballe LG; Andersen A; Pryds O; Nielsen SD; Benn CS; Jeppesen DL
BMC Infect Dis; 2017 Aug; 17(1):540. PubMed ID: 28774269
[TBL] [Abstract][Full Text] [Related]
24. Intravesical bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer.
Shelley MD; Court JB; Kynaston H; Wilt TJ; Coles B; Mason M
Cochrane Database Syst Rev; 2003; (3):CD003231. PubMed ID: 12917955
[TBL] [Abstract][Full Text] [Related]
25. Bacillus Calmette-Guérin vaccination at birth: Effects on early childhood infections, growth, and development.
Kjærgaard J
Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808041
[TBL] [Abstract][Full Text] [Related]
26. Environmental risk factors for non-Hodgkin's lymphoma: umbrella review and comparison of meta-analyses of summary and individual participant data.
Shi X; Zhuo H; Du Y; Nyhan K; Ioannidis J; Wallach JD
BMJ Med; 2022; 1(1):e000184. PubMed ID: 36936582
[TBL] [Abstract][Full Text] [Related]
27. Medical history and risk of Hodgkin's and non-Hodgkin's lymphomas.
Tavani A; La Vecchia C; Franceschi S; Serraino D; Carbone A
Eur J Cancer Prev; 2000 Feb; 9(1):59-64. PubMed ID: 10777011
[TBL] [Abstract][Full Text] [Related]
28. Risk of lymphoma and leukaemia after bacille Calmette-Guérin and smallpox vaccination: a Danish case-cohort study.
Villumsen M; Sørup S; Jess T; Ravn H; Relander T; Baker JL; Benn CS; Sørensen TI; Aaby P; Roth A
Vaccine; 2009 Nov; 27(49):6950-8. PubMed ID: 19747577
[TBL] [Abstract][Full Text] [Related]
29. Red meat intake and risk of non-Hodgkin lymphoma: a meta-analysis.
Fallahzadeh H; Cheraghi M; Amoori N; Alaf M
Asian Pac J Cancer Prev; 2014; 15(23):10421-5. PubMed ID: 25556486
[TBL] [Abstract][Full Text] [Related]
30. Determinants of Bacillus Calmette-Guérin (BCG) vaccination among Québec children.
Li J; Menzies D; Landry JS; Benedetti A; Rousseau MC
Prev Med; 2014 Sep; 66():87-94. PubMed ID: 24945693
[TBL] [Abstract][Full Text] [Related]
31. Neonatal Bacillus Calmette-Guérin Vaccination to Prevent Early-Life Eczema: A Systematic Review and Meta-analysis.
Pittet LF; Thøstesen LM; Aaby P; Kofoed PE; Curtis N; Benn CS
Dermatitis; 2022 Nov-Dec 01; 33(6S):S3-S16. PubMed ID: 36125788
[TBL] [Abstract][Full Text] [Related]
32. The role of Bacillus Calmette-Guérin administration on the risk of dementia in bladder cancer patients: a systematic review and meta-analysis.
Han C; Wang J; Chen YL; Guan CP; Zhang YA; Wang MS
Front Aging Neurosci; 2023; 15():1243588. PubMed ID: 37693645
[TBL] [Abstract][Full Text] [Related]
33. The prognostic value of tumour-associated macrophages in Non-Hodgkin's lymphoma: A systematic review and meta-analysis.
Xu X; Li Z; Liu J; Zhu F; Wang Z; Wang J; Zhang J; Wang H; Zhai Z
Scand J Immunol; 2020 Jan; 91(1):e12814. PubMed ID: 31419843
[TBL] [Abstract][Full Text] [Related]
34. A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements.
Wang L; Turner MO; Elwood RK; Schulzer M; FitzGerald JM
Thorax; 2002 Sep; 57(9):804-9. PubMed ID: 12200526
[TBL] [Abstract][Full Text] [Related]
35. Obesity and risk of non-Hodgkin's lymphoma: a meta-analysis.
Larsson SC; Wolk A
Int J Cancer; 2007 Oct; 121(7):1564-70. PubMed ID: 17443495
[TBL] [Abstract][Full Text] [Related]
36. Vaccination history and risk of non-Hodgkin lymphoma: a population-based, case-control study.
Lankes HA; Fought AJ; Evens AM; Weisenburger DD; Chiu BC
Cancer Causes Control; 2009 Jul; 20(5):517-23. PubMed ID: 19011978
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant bacillus Calmette-Guérin therapy in non-Hodgkin's malignant lymphomas: long-term results of a randomized trial in a single institution.
Ravaud A; Eghbali H; Trojani M; Hoerni-Simon G; Soubeyran P; Hoerni B
J Clin Oncol; 1990 Apr; 8(4):608-14. PubMed ID: 2179478
[TBL] [Abstract][Full Text] [Related]
38. Determining optimal maintenance schedules for adjuvant intravesical bacillus Calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer: a systematic review and network meta-analysis.
Huang Z; Liu H; Wang Y; Zhang C; Xu T
Curr Med Res Opin; 2017 Aug; 33(8):1379-1387. PubMed ID: 28471272
[TBL] [Abstract][Full Text] [Related]
39. BCG Vaccination and the Risk of Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Jamshidi P; Danaei B; Mohammadzadeh B; Arbabi M; Nayebzade A; Sechi LA; Nasiri MJ
Pathogens; 2023 Apr; 12(4):. PubMed ID: 37111467
[TBL] [Abstract][Full Text] [Related]
40. Benzene exposure increases the risk of non-Hodgkin's lymphoma: a systematic review and meta-analysis of observational studies.
Liu Y; Wang J
Transl Cancer Res; 2022 Jun; 11(6):1750-1761. PubMed ID: 35836544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
